Origins of Cancer Immunotherapy, ft. Dr. Steven Rosenberg
The ImmunoVerse™
00:00
Discovery and development of tumor-infiltrating lymphocytes (TIL)
Steven Rosenberg describes finding tumor-infiltrating lymphocytes as tumor-recognizing cells, growing them as living drugs, and the path to FDA approval for melanoma.
Transcript
Play full episode
